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Abstract 
We present the case of a 21-year-old man with advanced refractory Parkinson’s disease treated with Duodopa® 
continuous infusion. With this therapy, the patient had a spectacular recovery but after six months, he experienced an aggravation of 
his symptoms. A failure of his pumping system was suspected but we discovered that the jejunal tube was blocked due to a knot 
around a bezoar. This is the first complication of this kind described with the Duodopa infusion technique.  
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Introduction 
The continuous delivery of levodopa/carbidopa 
to the small intestine via a jejunal tube, formulated as a 
gel suspension (Duodopa®), represents a new treatment 
method in patients with advanced Parkinson disease [1].  
The continuous release results in less variability in 
levodopa concentrations and fewer motor fluctuations and 
dyskinesias than in oral administration [1]. 
This new technique implies a good cooperation 
between a neurologist and a gastroenterologist and uses 
a portable pump attached to a special tubing system. 
First, a classic PEG gastrostomy kit is placed under 
propofol sedation. This gastrostomy allows the passage of 
a pigtail catheter, which is deployed in the jejunum by 
using the endoscope and a rat tooth forceps. The 
procedure takes about 30 minutes in the expert hands 
and it can be carried out during a short admission in the 
hospital. 
The experience of European centers with this 
technique is increasing slowly mainly due to cost related 
issues. One of the largest series recently published 
included 65 patients followed for a medium period of 10.7 
years [2]. Fifty-two patients were treated for more than 1 
year. The adverse effect profile of levodopa/carbidopa 
infusion was comparable to that noticed after oral 
administration. Seven patients died, but all deaths were 
secondary to other causes and not to the procedure or the 
treatment. The most frequent problems were related to 
the intestinal tube placement, including dislocation of the 
stomach, which occurred in 69% of the patients during the 
first year [2]. The technical challenges posed by the 
enteral infusion system were offset by the improvement in 
motor fluctuations and dyskinesias offered by this 
technique for the majority of patients [2].  
Case presentation 
A 21-year-old male patient with long standing 
severe Parkinson’s disease was proposed for the 
Duodopa® continuous infusion treatment. In June 2009, a 
PEG tube was inserted under general sedation with 
propofol and a jejunal tube was placed allowing the debut 
of the treatment. The patient had a spectacular evolution 
of his neurological disease. The only complication was 
pain at the insertion point, due to which he received 
symptomatic treatment. 
Approximately six months after the system 
placement the patient consulted his neurologist for a 
pump malfunction (high-pressure alarm; blockage) and 
the aggravation of his symptoms. After a check up of the 
infusion system, which worked fine, we decided to verify 
the patency of his tubing system. The tube clogging is a 
frequent complication after PEG placement [3] and this 
was our initial suspicion. An attempt to pass a guide wire 
over the jejunal tube showed in fact a blockage after 40 
cm. The decision of tube removal was made and the 
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patient had an upper endoscopy. The PEG gastric tube 
was at its place, in good position, but the jejunal tube was 
knotted in the stomach around a bezoar. (Figure 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We decided to extract it with a polipectomy snare 
after cutting its abdominal side. The extraction was made 
easily and without complications. (Figure 2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Endoscopic view of the replacement jejunal tube (in 
place over a PEG gastrostomy).  
Fig. 1 The jejunal tube after extraction. 
Discussion 
As far as we know, this is the first incident of 
this type, occurring with the Duodopa® delivery 
system. The experience of seven cases (until now) in 
our centre is the biggest in Romania and showed no 
major drawbacks related to the delivery system 
montage or functioning. The PEG gastrostomy posing 
has a number of well-known complications but it is a 
common endoscopic procedure and, in expert hands, 
the complications are rarely seen [3].  
With the Duodopa® infusion method, no 
blockage due to a knot of the jejunal tube was yet 
reported. It came as a surprise to notice the way this 
knot was formed and, probably, the presence of the 
gastric bezoar and the patient’s lack of care while 
manipulating its jejunal tube (normally a forbidden 
maneuver) may have played an important role. Fig. 2 Jejunal tube, detail: A knot around a bezoar. 
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